IGF2BP2, CDKN2A, CDK5 and KCNQ1 are known to be implicated in the mass development, proliferation, and insulin secretory function of β-cells, and in metabolic processes in T2D-affected tissues [3,20,55,56]. The gene discussed is CDKN2A; the disease is type 2 diabetes mellitus.